HCPCS Codes Similar to V4

HCPCS Codes Similar to “V4” Code.
Demonstration modifier 4

V1 Demonstration modifier 1 Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	V2 Demonstration modifier 2 Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
V3 Demonstration modifier 3 Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	J1098 Articaine ophthalmic, 8% solution, 0.4 ml Code added date: 20260401 Code effective date: 20260401 TXT \| PDF \| XML \| JSON
G9066 Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9086 Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON
G9110 Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9115 Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON
G9135 Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project) Code added date: 20070101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9140 Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours Code added date: 20071001 Code effective date: 20071001 TXT \| PDF \| XML \| JSON
A2014 Omeza collagen matrix or omeza complete matrix, per 100 mg Code added date: 20221001 Code effective date: 20260401 TXT \| PDF \| XML \| JSON	A2037 G4derm plus/suprello, per milliliter Code added date: 20251001 Code effective date: 20260401 TXT \| PDF \| XML \| JSON
A2040 Microlyte painguard, per square centimeter Code added date: 20260401 Code effective date: 20260401 TXT \| PDF \| XML \| JSON	A2041 Foundation drs+ duo, per square centimeter Code added date: 20260401 Code effective date: 20260401 TXT \| PDF \| XML \| JSON